The Company designs, manufactures and markets professional, medical, industrial and consumer products, its business consists of four segments: Professional Instrumentation, Medical Technologies, Industrial Technologies and Tools & Components.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
The stock is currently undervalued on a future P/E perspective. DHR produces very consistent earnings and usually trades at a conservative 21x PE ratio. It is trading at 23.21x current earnings ratio on the expectation of a large Q1 2010 number.
Fair present value is:
2010 fair value of DHR:
P/E valuation: (21*4.13) = $86.73
2011 fair value of DHR:
P/E valuation: (21*4.72) = $99.12
Please see the Practice Due Diligence blog article for DHR for further research:
http://msncaps.fool.com/Blogs/ViewPost.aspx?bpid=374608&t=02003600157789065646
DHR is my highest conviction pick for the long term. DHR presents an opportunity to outperform the broad market at a very low risk for the foreseeable future.
Disclosure:
RL- Long Position in DHR is 18.6% of Total Portfolio
I added 30% to my position @ $82.50; I didn't catch the bottom of the dip but that is ok. I have a sell order in at $91.50 22x 2010 earnings.